Yusuke Kawamura

23PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)Nutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|May 03, 2025
Peripheral blood CD4+/CD8+ T cell ratio may have potential for predicting the treatment response of durvalumab plus tremelimumab therapy (STRIDE) for unresectable hepatocellular carcinoma: Preliminary report.

Yusuke Kawamura, Norio Akuta, Junichi Shindoh

|Sep 26, 2024
Newly established borderline resectable 1 (BR1) category is one of the favorable candidates for selecting the use of multidisciplinary combination therapy in patients with advanced hepatocellular carcinoma treated with systemic therapy.

Yusuke Kawamura, Norio Akuta, Junichi Shindoh

|Dec 19, 2023
A new imaging classification for safer radial access visceral intervention of the liver and optimal case selection: A preliminary report.

Yusuke Kawamura, Norio Akuta, Shunichiro Fujiyama

|Sep 16, 2023
Impact of genetic polymorphism on personalized diet and exercise program for steatotic liver disease.

Norio Akuta, Yusuke Kawamura, Shunichiro Fujiyama

|Aug 12, 2023
Efficacy of the Combination of Systemic Sequential Therapy and Locoregional Therapy in the Long-Term Survival of Patients with BCLC Stage C Hepatocellular Carcinoma.

Yusuke Kawamura, Norio Akuta, Junichi Shindoh

|Aug 03, 2023
Impact of fibrosis on liver-related event incidence in nonalcoholic fatty liver disease: A multicenter observational study.

Kazuaki Chayama, Akira Hiramatsu, Toshihide Shima

Pageof 4

Frequent Collaborators

11 joint publications

Shunichirou Fujiyama

10 joint publications

Norio Akuta

9 joint publications

Tetsuya Hosaka

3 joint publications

Hitomi Sezaki